Hemp has been legalized throughout the U.S. since 2018. Anxiety and pain can be managed by usage of CBD oil which is derived from hemp. There has been considerable increase in the sales of CBD products in the country. In 2014, the sale was $100 million with a steep rise in the sale with $845 million in 2019.
Even with the increase in consumption of the cannabinoid products there is no much information on how the CBD products interact with other medications a person is taking. Researchers from Penn State College of Medicine in Hershey, PA, are trying to bridge this knowledge gap.
As reported on a cbd news UK website, the researchers have published a list of prescription medications that might not work in combination with the medical cannabinoids, CBD oil, or medical or recreational cannabis. In all there are 57 medications that might get affected or interfere with the consumption of cannabinoid products, including cannabis and cannabidiol (CBD) oil alongside them.
This list mainly includes prescribed medications like anticoagulants, pain relievers, and birth control pills. The CBD products can impact the effects of a range of medicines that includes antidepressants (amitriptyline, clomipramine, and lofepramine), oral contraceptives (ethinylestradiol),opioid pain medications (fentanyl), thyroid hormones (levothyroxine), sedatives (propofol), and blood thinners (acenocoumarol and warfarin) when taken alongside.
These medicines have a narrow therapeutic index meaning there is a small margin between a therapeutic dose and a toxic one. This particular margin is increased due to the interaction and can thus result into a medical problem.
One can access the complete list on Penn State website. There is a complete document on the same with researchers having published a longer list of 139 other medicines too that have impacts with lower risk. They are routinely updating the lists as new drugs get approval or some new evidence emerges.